epilepsy - EUROPE SAYS

SK Life Science, Inc. Presents XCOPRI® (cenobamate tablets) CV Data at the AES 2024 Annual Meeting Showing a Deeper Understanding of Cenobamate's Dual Mechanism of Action

Read More

SK Life Science, Inc. to Present 10 Posters with New Cenobamate Data, Including a Late-Breaker, at the 2025 American Epilepsy Society (AES) Annual Meeting

21.11.2025

PARAMUS, N.J. , Nov. 21, 2025 /PRNewswire/ — SK Life Science, Inc., a global leader in treatments for…

Catalyst Pharmaceuticals Reports Record Fourth Quarter and Full Year 2024 Financial Results and Provides Business Update

Read More

Catalyst Pharmaceuticals Announces Health Canada’s

08.04.2025

CORAL GABLES, Fla., April 08, 2025 (GLOBE NEWSWIRE) — Catalyst Pharmaceuticals, Inc. (“Catalyst” or “Company”) (Nasdaq: CPRX), a…

RRoyal Families

The True Story of the British Royal Family's 'Lost Prince'

Read More

The True Story of the British Royal Family’s ‘Lost Prince’

20.03.2025

The British Royal Family have had their share of controversies over the years. From Edward VIII’s abdication to…